BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 16142918)

  • 1. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
    Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
    ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation.
    Huyer G; Ramachandran C
    Biochemistry; 1998 Mar; 37(9):2741-7. PubMed ID: 9485424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
    J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the binding specificity of the SH2 domains of protein tyrosine phosphatase SHP-1 through the screening of a combinatorial phosphotyrosyl peptide library.
    Beebe KD; Wang P; Arabaci G; Pei D
    Biochemistry; 2000 Oct; 39(43):13251-60. PubMed ID: 11052678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
    Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
    Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies on full length and the catalytic domain of the tandem SH2 domain-containing protein tyrosine phosphatase: analysis of phosphoenzyme levels and Vmax stimulatory effects of glycerol and of a phosphotyrosyl peptide ligand.
    Wang J; Walsh CT
    Biochemistry; 1997 Mar; 36(10):2993-9. PubMed ID: 9062130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations on the free and complexed N-terminal SH2 domain of SHP-2.
    Wieligmann K; Pineda De Castro LF; Zacharias M
    In Silico Biol; 2002; 2(3):305-11. PubMed ID: 12542415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W; Ullrich A
    Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
    Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidyl aldehydes as reversible covalent inhibitors of SRC homology 2 domains.
    Park J; Fu H; Pei D
    Biochemistry; 2003 May; 42(17):5159-67. PubMed ID: 12718560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position.
    Imhof D; Wavreille AS; May A; Zacharias M; Tridandapani S; Pei D
    J Biol Chem; 2006 Jul; 281(29):20271-82. PubMed ID: 16702225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of linear and cyclic phosphopeptides as ligands for the N-terminal SH2-domain of protein tyrosine phosphatase SHP-1.
    Imhof D; Nothmann D; Zoda MS; Hampel K; Wegert J; Böhmer FD; Reissmann S
    J Pept Sci; 2005 Jul; 11(7):390-400. PubMed ID: 15635669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.